Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Mar 7, 2022; 28(9): 933-947
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.933
Table 1 Clinicopathological features of patients with gastric cancer
Characteristics
Total (N = 2983)
Female (n = 978)
Male (n = 2005)
P value
Age (yr, mean ± SD)60.91 ± 12.3159.36 ± 13.4761.66 ± 11.63< 0.001a
Drinking history, n (%)
No1631 (54.7)790 (80.8)841 (41.9)< 0.001a
Yes1352 (45.3)188 (19.2)1164 (58.1)
Smoking history, n (%)
No1645 (55.1)902 (92.2)743 (37.1)< 0.001a
Yes1338 (44.9)76 (7.8)1262 (62.9)
Family history, n (%)
No2467 (82.7)803 (82.1)1664 (83.0)0.548
Yes516 (17.3)175 (17.9)341 (17.0)
Tumor location, n (%)
Upper77 (2.6)19 (2.0)58 (2.9)< 0.001a
Middle1332 (44.6)497 (50.8)835 (41.6)
Lower1574 (52.8)462 (47.2)1112 (55.5)
Atrophic gastritis, n (%)
No2162 (72.5)751 (76.8)1411 (70.4)< 0.001a
Yes821 (27.5)227 (23.2)594 (29.6)
Intestinal metaplasia, n (%)
No1680 (56.3)560 (57.3)1120 (55.9)0.469
Yes1303 (43.7)418 (42.7)885 (44.1)
T stage, n (%)
T12134 (71.5)696 (71.2)1438 (71.7)0.669
T2330 (11.1)102 (10.4)228 (11.4)
T3420 (14.1)144 (14.7)276 (13.8)
T499 (3.3)36 (3.7)63 (3.1)
N stage, n (%)
N02215 (74.3)696 (71.2)1519 (75.7)0.014a
N1423 (14.2)163 (16.7)260 (13.0)
N2174 (5.8)66 (6.7)108 (5.4)
N3171 (5.7)53 (5.4)118 (5.9)
Stage, n (%)
I2312 (77.5)743 (76.0)1569 (78.3)0.189
II405 (13.6)151 (15.4)254 (12.7)
III212 (7.1)69 (7.1)143 (7.1)
IV54 (1.8)15 (1.5)39 (1.9)
Cancer type, n (%)
EGC2133 (71.5)696 (71.2)1437 (71.7)0.774
AGC850 (28.5)282 (28.8)568 (28.3)
Histologic type, n (%) (Lauren classification)
Intestinal1843 (61.8)447 (45.7)1396 (69.6)< 0.001a
Diffuse1014 (34.0)494 (50.5)520 (25.9)
Mixed126 (4.2)37 (3.8)89 (4.5)
H. pylori status, n (%)
Negative1267 (42.5)379 (38.8)888 (44.3)0.004a
Positive1716 (57.5)599 (61.2)1117 (55.7)
P53, n (%)
Negative1917 (64.3)706 (72.2)1211 (60.4)< 0.001a
Positive1066 (35.7)272 (27.8)794 (39.6)